Evidence map›Paper›PMID 39156982›Full record

ArticleFarmaceuticos comunitarios2023

[Detection of nephrotoxics and dose adjustment in patients with low glomerular filtration rate in community pharmacy: methodology].

Gema Escribá-Martí, Iker Cámara-Ramos, Maria Teresa Climent-Catalá, Verónica Escudero-Quesada, Luis Salar-Ibáñez

Abstract readEnglish Abstract
In one paragraph

Article in Farmaceuticos comunitarios, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Gema Escribá-MartíFarmacéutica comunitaria en Segart (Valencia). España.
Iker Cámara-RamosFarmacéutico comunitario en Bilbao. España.
Maria Teresa Climent-CataláFarmacéutica comunitaria en L'Olleria (Valencia). España.
Verónica Escudero-QuesadaNefróloga. Servicio de Nefrología del Hospital Universitario Dr. Peset (Valencia). Hospital Universitario Dr. Peset España.
Luis Salar-IbáñezFarmacéutico comunitario en Valencia. Profesor asociado Universidad Cardenal Herrera - CEU. Universidad Cardenal Herrera España.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Abstract: Chronic kidney disease is a prevalent problem without specific treatment. Early detection is important and estimated glomerular filtration rate (eGFR) is a very affordable test that can be performed in community pharmacies. If present, it is very important not to further damage the kidney by avoiding the use of nephrotoxic drugs and adjusting the doses of other renal elimination drugs and the community pharmacy is very well positioned to do this. Objective: To describe the methodology used to detect nephrotoxic drugs and adjust doses of other drugs in community pharmacies for subsequent referral to primary care. Method: Multicentre experimental multicentre uncontrolled follow-up study carried out in community pharmacies in 4 autonomous communities in Spain. Patients who met the inclusion criteria and signed the informed consent form were included. Those with eGFR <60 ml/min/1.73m Result: 670 patients were included, 215 of them with eGFR<60ml/min/1.73m Conclusion: In patients with low glomerular filtration rate, with the appropriate methodology, the community pharmacist is able to detect the use of nephrotoxic drugs or the use of drugs at doses higher than those recommended according to their renal status.

Indexed as

Chronic kidney diseaseCommunity pharmaciesDose adjustmentNephrotoxic

Identifiers

PMID39156982
PMCPMC11326692

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.